The harm reduction program shall provide participants with:

A. sterile hypodermic syringes and needles in exchange for used hypodermic syringes, needles or other objects used to inject controlled substances or controlled substance analogs into the human body;

B. other objects used to prepare or consume controlled substances or controlled substance analogs;

C. supplies or devices used for testing controlled substances or controlled substance analogs for potentially dangerous adulterants;

D. supplies or devices approved by the department for distribution in accordance with rules established pursuant to Subsection E of Section 24-2C-4 N.M. Stat. Ann.;

E. education on the prevention of:

C; and

(1)     the transmission of the human immunodeficiency virus and hepatitis B and (2)     drug overdose mortality and other negative health outcomes; and

F. referral to substance abuse treatment services.